GlassScriptPhysician profile
Di Zhou
NPI 1023435948
$3,292.16
in general payments reported to CMS, 2019-2025
16 companies · $257 in 2025
The $257 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $283 · 2021: $313 · 2022: $263 · 2023: $367 · 2024: $1,503 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,250 · Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,250.00 |
| Food and Beverage | $877.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $1,250.00 | 2024 | Visumax |
| Alcon Vision LLC | $612.72 | 2019-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Biotissue Holdings INC. | $251.61 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $249.01 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $203.97 | 2024 | Miebo, Xiidra, Doctors Allergy Formula |
| Aerie Pharmaceuticals, INC. | $176.28 | 2021 | |
| Eyepoint US, INC. | $125.01 | 2020 | |
| Oyster Point Pharma, INC. | $100.40 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $100.37 | 2019 | |
| Kala Pharmaceuticals, INC. | $56.48 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.52 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $35.17 | 2023 | Acuvue |
| Coopervision INC. | $31.54 | 2023 | Ortho-K Contact Lens |
| Allergan, INC. | $28.85 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $15.29 | 2023 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $12.94 | 2023 | Cequa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Di Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.